The American Academy of Pediatrics (AAP) has published its first clinical practice guideline on the use of opioid medications to manage acute pain in children and adolescents.

Coverage lower for those covered by Medicaid or other nonprivate insurance, uninsured children, children living below federal poverty level ...

HealthDay News — Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression, according to a study presented at the annual meeting of the ...

HealthDay News — The free COVID-19 tests promised by the US government are now available. “US households will be eligible to order four free COVID-19 tests at COVIDTests.gov ,” according to the US ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

Significantly greater reduction from baseline seen in Wang bronchiolitis clinical score at day 3 for those aged 1 to 24 months ...

HealthDay News — In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in ...

"Children are the overlooked tragic victims of the United States' opioid epidemic, and fentanyl is now the greatest danger." HealthDay News — Opioid poisonings are increasing among children, according ...

Xanomeline and trospium chloride is a first-in-class medication that selectively targets the M1 and M4 receptors without blocking D2 receptors.

To provide more robust evidence for clinicians, investigators analyzed the efficacy and safety of biologics in patients with lupus nephritis using meta-regression analyses that adjusted for trials’ ...

PTC518 was granted Fast Track designation based off strong 12-month interim data on safety and efficacy.

Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions.